Yara International ASA (OTCMKTS:YARIY – Free Report) – Analysts at Scotiabank raised their FY2024 earnings estimates for Yara International ASA in a research report issued on Monday, October 28th. Scotiabank analyst B. Isaacson now anticipates that the basic materials company will post earnings per share of $1.21 for the year, up from their previous estimate of $1.11. The consensus estimate for Yara International ASA’s current full-year earnings is $0.83 per share. Scotiabank also issued estimates for Yara International ASA’s FY2025 earnings at $1.75 EPS.
Separately, Redburn Atlantic raised shares of Yara International ASA to a “strong sell” rating in a research note on Friday, October 18th.
Yara International ASA Price Performance
Shares of YARIY stock opened at $15.23 on Thursday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.71 and a quick ratio of 0.95. The firm’s 50-day moving average is $15.09 and its two-hundred day moving average is $14.71. Yara International ASA has a 12 month low of $13.25 and a 12 month high of $17.99. The company has a market capitalization of $7.76 billion, a PE ratio of -217.57 and a beta of 0.93.
Yara International ASA Company Profile
Yara International ASA provides crop nutrition and industrial solutions in Norway, European Union, Europe, Africa, Asia, North and Latin America, Australia, and New Zealand. The company offers ammonium- and urea-based fertilizers; compound fertilizers that contain nutrients, such as nitrogen, phosphorus, and potassium; coatings; biostimulants; organic-based fertilizers; green fertilizers are nitrate-based mineral fertilizers, as well as foliar and fertigation solutions; and nitrate, calcium nitrate, micronutrient, and fertigation and urea fertilizers.
Featured Stories
- Five stocks we like better than Yara International ASA
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Applied Materials vs ASML: Which is the Best Chip Stock to Own?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Top Bill Gates Stock Picks Every Investor Should Know About
- How to Calculate Stock Profit
- Viking Therapeutics Stock: A Pre-Election Bet Worth Considering
Receive News & Ratings for Yara International ASA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yara International ASA and related companies with MarketBeat.com's FREE daily email newsletter.